Cargando…
Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis
BACKGROUND: Non-invasive pneumococcal pneumonia causes significant morbidity and mortality in older adults. Understanding pneumococcal sero-epidemiology in adults ≥50 years is necessary to inform vaccination policies and the updating of pneumococcal vaccines. METHODS: We conducted a systematic revie...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790487/ https://www.ncbi.nlm.nih.gov/pubmed/35112072 http://dx.doi.org/10.1016/j.eclinm.2022.101271 |
_version_ | 1784640021934899200 |
---|---|
author | Lansbury, Louise Lim, Benjamin McKeever, Tricia M Lawrence, Hannah Lim, Wei Shen |
author_facet | Lansbury, Louise Lim, Benjamin McKeever, Tricia M Lawrence, Hannah Lim, Wei Shen |
author_sort | Lansbury, Louise |
collection | PubMed |
description | BACKGROUND: Non-invasive pneumococcal pneumonia causes significant morbidity and mortality in older adults. Understanding pneumococcal sero-epidemiology in adults ≥50 years is necessary to inform vaccination policies and the updating of pneumococcal vaccines. METHODS: We conducted a systematic review and random-effects meta-analysis to determine the proportion of community-acquired pneumonia (CAP) in people ≥50 years due to pneumococcus and the proportion caused by pneumococcal vaccine serotypes. We searched MEDLINE, EMBASE and PubMed from 1 January 1990 to 30 March 2021. Heterogeneity was explored by subgroup analysis according to a) patient group (stratified versus age) and depth of testing, b) detection/serotyping method, and c) continent. The protocol is registered with PROSPERO (CRD42020192002). FINDINGS: Twenty-eight studies were included (34,216 patients). In the period 1–5 years after introduction of childhood PCV10/13 immunisation, 18% of CAP cases (95% CI 13–24%) were attributable to pneumococcus, with 49% (43–54%) of pneumococcal CAP due to PCV13 serotypes. The estimated proportion of pneumococcal CAP was highest in one study that used 24-valent serotype-specific urinary-antigen detection (ss-UAD)(30% [28–31%]), followed by studies based on diagnostic serology (28% [24–33%]), PCR (26% [15–37%]), ss-UAD14 (17% [13–22%]), and culture alone (14% [10–19%]). A higher estimate was observed in Europe (26% [21–30%] than North America (11% [9–12%](p<0·001). PCV13-serotype estimates were also influenced by serotyping methods. INTERPRETATION: Non-invasive pneumococcal CAP and vaccine-type pneumococcal CAP remains a burden in older adults despite widespread introduction of pneumococcal infant immunisation. Studies heavily reliant on ss-UADs restricted to vaccine-type serotypes may overestimate the proportion of potentially vaccine-preventable pneumococcal pneumonia. Sero-epidemiological data from low-income countries are lacking. |
format | Online Article Text |
id | pubmed-8790487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87904872022-02-01 Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis Lansbury, Louise Lim, Benjamin McKeever, Tricia M Lawrence, Hannah Lim, Wei Shen EClinicalMedicine Articles BACKGROUND: Non-invasive pneumococcal pneumonia causes significant morbidity and mortality in older adults. Understanding pneumococcal sero-epidemiology in adults ≥50 years is necessary to inform vaccination policies and the updating of pneumococcal vaccines. METHODS: We conducted a systematic review and random-effects meta-analysis to determine the proportion of community-acquired pneumonia (CAP) in people ≥50 years due to pneumococcus and the proportion caused by pneumococcal vaccine serotypes. We searched MEDLINE, EMBASE and PubMed from 1 January 1990 to 30 March 2021. Heterogeneity was explored by subgroup analysis according to a) patient group (stratified versus age) and depth of testing, b) detection/serotyping method, and c) continent. The protocol is registered with PROSPERO (CRD42020192002). FINDINGS: Twenty-eight studies were included (34,216 patients). In the period 1–5 years after introduction of childhood PCV10/13 immunisation, 18% of CAP cases (95% CI 13–24%) were attributable to pneumococcus, with 49% (43–54%) of pneumococcal CAP due to PCV13 serotypes. The estimated proportion of pneumococcal CAP was highest in one study that used 24-valent serotype-specific urinary-antigen detection (ss-UAD)(30% [28–31%]), followed by studies based on diagnostic serology (28% [24–33%]), PCR (26% [15–37%]), ss-UAD14 (17% [13–22%]), and culture alone (14% [10–19%]). A higher estimate was observed in Europe (26% [21–30%] than North America (11% [9–12%](p<0·001). PCV13-serotype estimates were also influenced by serotyping methods. INTERPRETATION: Non-invasive pneumococcal CAP and vaccine-type pneumococcal CAP remains a burden in older adults despite widespread introduction of pneumococcal infant immunisation. Studies heavily reliant on ss-UADs restricted to vaccine-type serotypes may overestimate the proportion of potentially vaccine-preventable pneumococcal pneumonia. Sero-epidemiological data from low-income countries are lacking. Elsevier 2022-01-24 /pmc/articles/PMC8790487/ /pubmed/35112072 http://dx.doi.org/10.1016/j.eclinm.2022.101271 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Lansbury, Louise Lim, Benjamin McKeever, Tricia M Lawrence, Hannah Lim, Wei Shen Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis |
title | Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis |
title_full | Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis |
title_fullStr | Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis |
title_full_unstemmed | Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis |
title_short | Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis |
title_sort | non-invasive pneumococcal pneumonia due to vaccine serotypes: a systematic review and meta-analysis |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790487/ https://www.ncbi.nlm.nih.gov/pubmed/35112072 http://dx.doi.org/10.1016/j.eclinm.2022.101271 |
work_keys_str_mv | AT lansburylouise noninvasivepneumococcalpneumoniaduetovaccineserotypesasystematicreviewandmetaanalysis AT limbenjamin noninvasivepneumococcalpneumoniaduetovaccineserotypesasystematicreviewandmetaanalysis AT mckeevertriciam noninvasivepneumococcalpneumoniaduetovaccineserotypesasystematicreviewandmetaanalysis AT lawrencehannah noninvasivepneumococcalpneumoniaduetovaccineserotypesasystematicreviewandmetaanalysis AT limweishen noninvasivepneumococcalpneumoniaduetovaccineserotypesasystematicreviewandmetaanalysis |